While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life sciences industry appears to be spending more money developing fewer drugs.
According to the latest data, the cost to take a drug candidate from the discovery stage, all the way to market launch, hit $2.3 billion in 2022—a $298 million rise from 2021. Meanwhile, there were
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
MCG Secures $5.7M NIH Grants to Study Cardiovascular Complications of HIV
What You Should Know:
- Two new National Institutes of Health grants, totaling $5.7 million, are aimed at helping scientists at the Medical College of Georgia at Augusta University better understand the mechanisms of two cardiovascular complications associated with HIV.
- Thanks to the advent of combination antiretroviral therapy (cART), which uses a combination of three or more drugs to stop the virus from replicating in the body, life expectancy of people living with HIV has
Read More
OneCell Diagnostics Raises $16M for Genomics-Based Precision Oncology Platform
What You Should Know:
- OneCell Diagnostics, a genomics-based precision oncology company, announced today that it has raised $16M in an oversubscribed Series A funding round led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures.
- The funding will be used to advance its vision of democratizing precision oncology through cancer diagnostic testing that is more accessible, actionable, and affordable. Celesta Capital Founding
Read More
Converge Bio Raises $5.5M to Accelerate Drug Discovery with GenAI
What You Should Know:
- Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners.
- Converge Bio's platform uses large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotech and pharmaceutical companies discover and develop better-performing drugs in less time.
Converge Bio: Advancing Biotech and Pharma
Read More
GeneDx Launches Tool to Fuel Rare Disease Drug Discovery
What You Should Know:
- GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
- The platform provides biopharmaceutical companies with access to de-identified and aggregated genetic data, empowering them to accelerate the development of new therapies.
Addressing the Challenges of Drug Development
The traditional drug development process is
Read More
Abbott Opens State-of-the-Art Diabetes Care Manufacturing Facility in Kilkenny, Ireland
What You Should Know:
- Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
- Abbott's FreeStyle Libre portfolio is the world's leading continuous glucose monitoring system, helping more than 6 million people with diabetes across over 60 countries.
Boosting Irish Economy and Manufacturing Capabilities
The Kilkenny facility is part of a €440 million
Read More
NVIDIA BioNeMo Framework Accelerates AI Drug Discovery
What You Should Know:
- NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
- The framework provides a powerful suite of tools for scaling AI models in biomolecular research, bringing supercomputing capabilities to the forefront of drug development.
Accelerating Drug Discovery with AI
The BioNeMo Framework addresses the growing need
Read More
How Temporal Artery Thermometry Improves Patient Safety Through Accurate Temperature Monitoring
Accurate and frequent temperature monitoring is paramount when it comes to ensuring favorable patient outcomes in the medical community. When a patient is admitted to the hospital, identifying illness or infection quickly has a profound impact on allowing for prompt treatment with antibiotics and can also be critical in the early identification of serious, life-threatening conditions like sepsis.
With the proliferation of less accurate temperature monitoring options during the
Read More
Navigating the Complexities of Preclinical and Clinical Trials
The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which are vital for transitioning from laboratory research to clinical application. Let us take a look at the whole process – step by step.
Preclinical Studies: Laying the Groundwork
The preclinical phase involves extensive in vitro (test tube or cell culture) and
Read More
Q/A: Funding Landscape: IPO or Buyout for Life Science Companies?
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth, or is a strategic buyout from a larger company a more suitable path?
In this exclusive interview, Taylor Wirth, a partner at Barnes & Thornburg, offers his insights on evaluating market conditions, assessing company readiness, and weighing the pros and cons of each funding option. He
Read More
